Financhill
Back

Health Catalyst 10K Form

Buy
61

HCAT
Health Catalyst

Last Price:
8.51
Seasonality Move:
3.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HCAT News And Ratings

See the #1 stock for the next 7 days that we like better than HCAT

HCAT Financial Statistics

Sales & Book Value

Annual Sales: $295.94M
Cash Flow: $1.79M
Price / Cash Flow: 0
Annual Sales: $5.83
Price / Book: 1.46

Profitability

EPS (TTM): -1.35000
Net Income (TTM): $-79.14M
Gross Margin: $131.83M
Return on Equity: -21.76%
Return on Assets: -10.95%

Health Catalyst Earnings Forecast

Key Health Catalyst Financial Ratios

  • The Gross Profit Margin over the past 7 years for HCAT is 44.55%.
  • The Selling, General & Administrative Expenses for HCAT have been equal to 48.62% of Gross Profit Margin.
  • The Research & Development expenses have been 24.54% of Revenue.
  • The Interest Expense is -6.17% of Operating Income.
  • The Net Earning history of HCAT is -39.92% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Health Catalyst Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: HCAT
CUSIP: 42225T
Website: healthcatalyst.com

Debt

Debt-to-Equity Ratio: 0.97
Current Ratio: 1.41
Quick Ratio: 1.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 21.11

HCAT Technical Analysis vs Fundamental Analysis

Buy
61
Health Catalyst (HCAT) is a Buy

Is Health Catalyst a Buy or a Sell?

  • Health Catalyst stock is rated a Buy
    The current Health Catalyst [HCAT] share price is $8.52. The Score for HCAT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.